Publications by authors named "Jodi Layton"

Claim this Profile
P
Prediction of Resistance to Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers.
Oliver Sartor, Elisa Ledet, Minqi Huang, Jennifer Schwartz, Alex Lieberman, Jodi Layton

J Nucl Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.
Albert Jang, Sree M Lanka, Minqi Huang, Crystal V Casado, Sydney A Caputo, Jodi L Layton

Prostate· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancer.
Sydney A Caputo, Madeline Hawkins, Ellen B Jaeger, William Fleming, Crystal Casado, Jodi Lyn Layton

Prostate· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience.
Albert Jang, Ellen B Jaeger, Elisa M Ledet, John Xie, Brian E Lewis, Jodi L Layton

Clin Genitourin Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab.
Charlotte Manogue Hawkins, Pedro C Barata, Patrick Cotogno, Gaynelle Davis, Ellen Jaeger, Jodi Layton

Oncologist· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous IV Infusion of 5-Flourouracil in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer.
Charlotte Manogue, William Fleming, Elisa Ledet, Ellen Jaeger, Jodi Layton

Clin Genitourin Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embracing the Practical Aspects of Theranostics With Prostate-Specific Membrane Antigen-Targeted Lutetium-177.
Charlotte E Manogue, Wenzhou Chen, Anthony Mazza, Audrey Dang, Brian Lewis, Jodi Layton

Pract Radiat Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer.
Marcus Moses, Alex Niu, Michael B Lilly, Andrew W Hahn, Roberto Nussenzveig, Jodi Layton

Cancer Treat Res Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
Rachel A Sabol, Elisa M Ledet, Ellen Jaeger, Whitley Hatton, Marcus Moses, Jodi L Layton

Prostate· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Elisa M Ledet, Earle F Burgess, Alexandra O Sokolova, Ellen B Jaeger, Whitley Hatton, Jodi Layton

Prostate· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next Generation of Androgen Deprivation Therapy Combined With Radiotherapy for N0 M0 Prostate Cancer.
Pedro Barata, Jodi Layton, Brian Lewis, Oliver Sartor

Cancer J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort.
Pedro Barata, Whitley Hatton, Arpita Desai, Vadim Koshkin, Ellen Jaeger, Jodi Layton

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Disease Control Using Taxane/Platinum-Based Chemotherapy in CDK12-Mutated Advanced Prostate Cancer.
Pedro Barata, Elisa Ledet, Charlotte Manogue, Patrick Cotogno, Kendra Harris, Jodi Layton

Oncologist· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
Pedro Barata, Neeraj Agarwal, Roberto Nussenzveig, Benjamin Gerendash, Ellen Jaeger, Jodi Layton

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer.
Lynne Chapman, Elisa M Ledet, Pedro C Barata, Patrick Cotogno, Charlotte Manogue, Jodi L Layton

Clin Genitourin Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer.
Marcus Moses, Ulkuhan Koksal, Elisa Ledet, Charlotte Manogue, Patrick Cotogno, Jodi Layton

Oncotarget· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer.
Bryce Raymon Christensen, Pedro C Barata, Elisa M Ledet, Jodi L Layton, Brian E Lewis

Clin Genitourin Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs.
Jodi L Layton, Brian Lewis, Charles Ryan, Tomasz M Beer, Oliver Sartor

Oncologist· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced blood management strategies for elective joint arthroplasty.
Jodi L Layton, Lee E Rubin, Joseph D Sweeney

R I Med J (2013)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-AIDS defining cancers.
Jodi L Layton, Jorge J Castillo

Med Health R I· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts.
Salma Rahimi, Zhiping Qian, Jodi Layton, Karen Fox-Talbot, William M Baldwin

Am J Transplant· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis